F2-isoprostanes: A measure of oxidative stress in children receiving treatment for leukemia

Biological Research for Nursing

Volumn 16, Issue 3, 2014, Pages 303-309

  Hockenberry, Marilyn J ^a   Taylor, Olga A ^b   Gundy, Patricia M ^c   Ross, Adam K ^c   Pasvogel, Alice ^c   Montgomery, David ^d   Ribbeck, Phillip ^b   Mccarthy, Kathy ^b   Moore, Ida ^c  

^a DUKE UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF NURSING   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Cancer; Methotrexate; Oxidative stress

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE; METHOTREXATE;

ADOLESCENT; CEREBROSPINAL FLUID; CHILD; DOSE RESPONSE; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PHYSIOLOGY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; BIOMARKERS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; F2-ISOPROSTANES; FEMALE; HUMANS; MALE; METHOTREXATE; OXIDATIVE STRESS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84905055710     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800413498507     Document Type: Article

References (48)

1. Anderson, V., Smibert, E., Ekert, H., & Godber, T. (1994). Intellectual, educational, and behavioural sequelae after cranial irradiation and chemotherapy. Archives of Disease in Childhood, 70, 476-483.
2. Babiak, R. M., Campello, A. P., Carnieri, E. G., & Oliveira, M. B. (1998). Methotrexate: Pentose cycle and oxidative stress. Cell Biochemistry and Function, 16, 283-293.
3. Barocas, D., Motley, S., Cookson, M., Chang, S., Penson, D., Dai, Q., & Fowke, J. H. (2011). Oxidative stress measured by urine F2- isoprostane level is associated with prostate cancer. Journal of Urology, 185, 2102-2107.
4. Block, G., Dietrich, M., Norkus, E. P., Morrow, D., Hudes, M., Caan, B., & Packer, L. (2002). Factors associated with oxidative stress in human populations. American Journal of Epidemiology, 156, 274-285.
5. Brown, R. T., Sawyer, M. B., Antoniuo, G., Toogood, I., Rice, M., Thompson, N., & Madan-Swain, A. (1996). A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia. Journal of Developmental and Behavioral Pediatrics, 17, 392-398.
6. Buizer, A. I., de Sonneville, L. M., van den Heuvel-Eibrink M. M., Njiokiktjien C & Veerman A. J. (2005). Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Journal of the International Neuropsychological Society, 11, 554-565.
7. Buizer, A. I., de Sonneville, L. M., van den Heuvel-Eibrink, M. M., & Veerman, A. J. (2006). Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor. Cancer, 106, 2067-2075.
8. Carey, M. E., Hockenberry, M. J., Moore, I. M., Hutter, J. J., Krull, K. R., Pasvogel, A., & Kaemingk, K. L. (2007). Brief report: Effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia. Journal of Pediatric Psychology, 32, 189-193.
9. Caron, J. E., Krull, K. R., Hockenberry, M. J., Jain, N., Kaemingk, K., & Moore, I. M. (2009). Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia. Pediatric Blood & Cancer, 53, 551-556.
10. Espy, K. A., Moore, I. M., Kaufmann, P. M., Kramer, J. H., Matthay, K., & Hutter, J. J. (2001). Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: A prospective study. Journal of Pediatric Psychology, 26, 1-9.
11. Fam, S., & Morrow, J. (2003). The isoprostanes: Unique products of arachidonic acid oxidation-A review. Current Medicinal Chemistry, 10, 1723-1740.
12. Girotti, A. W. (1998). Lipid hydroperoxide generation, turnover, and effector action in biological systems. Journal of Lipid Research, 39, 1529-1542.
13. Grosso, S., Longini, M., Rodriquez, A., Proietti, F., Piccini, B., Balestri, P., & Buonocore, G. (2011). Oxidative stress in children affected by epileptic encephalopathies. Journal of the Neurological Sciences, 300, 103-106.
14. Halberg, F. E., Kramer, J. H., Moore, I. M.,Wara, W. M., Matthay, K. K., & Ablin, A. R. (1992). Prophylactic cranial irradiation dose effects on late cognitive function in children treated for acute lymphoblastic leukemia. International Journal of Radiation, Oncology, Biology, and Physics, 22, 13-16.
15. Halliwell, B., & Whiteman, M. (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean? British Journal of Pharmacology, 142, 231-255.
16. Hockenberry, M., Krull, K., Moore, I. M., Gregurich, M. A., & Kaemingk, K. (2007). Longitudinal evaluation of fine motor skills in children with leukemia. Journal of Pediatric Hematology and Oncology, 29, 535-539.
17. Hopkins, M., Fedirko, V., Jones, D., Terry, P., & Bostick, R. (2010). Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: Results from a randomized, controlled clinical trial. Cancer Epidemiology, Biomarkers & Prevention, 19, 850-858.
18. Il'yasova, D., Kennedy, K., Spasojevic, I., Wang, F., Tolun, A. A., Base, K., & Dewhirst, M. W. (2011). Individual responses to chemotherapy-induced oxidative stress. Breast Cancer Research and Treatment, 125, 583-589.
19. Il'yasova, D., Spasojevic, I.,Wang, F., Tolun, A. A., Base, K., Young, S. P., & Millington, D. S. (2010). Urinary biomarkers of oxidative status in a clinical model of oxidative assault. Cancer Epidemiology, Biomarkers & Prevention, 19, 1506-1510.
20. Illingworth, D. R., & Glover, J. (1971). The composition of lipids in cerebrospinal fluid of children and adults. Journal of Neurochemistry, 18, 769-776.
21. Jahovic, N., Cevik, H., Sehirli, A. O., Yegen, B. C., & Sener, G. (2003). Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. Journal of Pineal Research, 34, 282-287.
22. Kaemingk, K. L., Carey, M. E., Moore, I. M., Herzer, M., & Hutter, J. J. (2004). Math weaknesses in survivors of acute lymphoblastic leukemia compared to healthy children. Child Neuropsychology, 10, 14-23.
23. Lehtinen, S. S., Huuskonen, U. E., Harila-Saari, A. H., Tolonen, E. U., Vainionpää, L. K., & Lanning, B. M. (2002). Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia. Cancer, 94, 2466-2473.
24. Margaill, I., Plotkine, M., & Lerouet, D. (2005). Antioxidant strategies in the treatment of stroke. Free Radical Biology & Medicine, 39, 429-443.
25. Mennes, M., Stiers, P., Vandenbussche, E., Vercruysse, G., Uyttebroeck, A., DeMeyer, G., &Van Cool S.W. (2005). Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatric Blood&Cancer, 44, 478-486.
26. Miketova, P., Kaemingk, K., Hockenberry, M., Pasvogel, A., Hutter, J., Krull, K., & Moore, I.M. (2005). Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia. Biological Research for Nursing, 6, 187-195.
27. Milne, G., Gao, L., Porta, A., Zanoni, G., Vidari, G., & Morrow, J. (2005). Identification of the major urinary metabolite of the highly reactive cyclopentenone isoprostane 15-A(2t)-isoprostane in vivo. Journal of Biological Chemistry, 280, 25178-25184.
28. Moe, P. J., & Holen, A. (2000). High-dose methotrexate in childhood ALL. Pediatric Hematology & Oncology, 17, 615-622.
29. Montour-Proulx, I., Kuehn, S. M., Keene, D. L., Barrowman, N. J., Hsu, E., Matzinger, M. A., & Halton, J. M. (2005). Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. Journal of Child Neurology, 20, 129-133.
30. Moore, B. D, III, Copeland, D. R., Ried, H., & Levy, B. (1992). Neurophysiological basis of cognitive deficits in long-term survivors of childhood cancer. Archives of Neurology, 49, 809-817.
31. Moore, I. M., Espy, K. A., Kaufmann, P., Kramer, J., Kaemingk, K., Miketova, P., & Matthay, K. (2000). Cognitive consequences and central nervous system injury following treatment for childhood leukemia. Seminars in Oncology Nursing, 16, 279-290.
32. Moore, I. M., Miketova, P., Hockenberry, M., Krull, K., Pasvogel, A., Carey, M., & Kaemingk, K. (2008). Methotrexate-induced alterations in beta-oxidation correlate with cognitive abilities in children with acute lymphoblastic leukemia. Biological Research for Nursing, 9, 311-319.
33. Osterlundh, G., Kjellmer, I., Lannering, B., Rosengren, L., Nilsson, U. A., & Márky, I. (2008). Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children. Pediatric Blood & Cancer, 50, 793-798.
34. Protas, P. T., Muszynska-Roslan, K., Holownia, A., Krawczuk-Rybak, M., & Braszko, J. J. (2010). Cerebrospinal fluid oxidative stress during chemotherapy of acute lymphoblastic leukemia in children. Pediatric Hematology and Oncology, 27, 306-313.
35. Pui, C. H., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012). Pediatric acute lymphoblastic leukemia: Where are we going and how do we get there? Blood, 120, 1165-1174.
36. Qin, J., Goswami, R., Balabanov, R., & Dawson, G. (2007). Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. Journal of Neuroscience Research, 85, 977-984.
37. Rajamani, R., Muthuvel, A., Senthilvelan, M., & Sheeladevi, R. (2006). Oxidative stress induced by methotrexate alone and in the presence of methanol in discrete regions of the rodent brain, retina and optic nerve. Toxicology Letters, 165, 265-273.
38. Raymond-Speden, E., Tripp, G., Lawrence, B., & Holdaway, D. (2000). Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia. Journal of Pediatric Psychology, 25, 59-68.
39. Reddick, W. E., Glass, J. O., Helton, K. J., Langston, J. W., Li, C. S., & Pui, C. H. (2005). A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation. American Journal of Neuroradiology, 26, 2371-2377.
40. Reddick, W. E., Glass, J. O., Helton, K. J., Langston, J. W., Xiong, X., Wu, S., & Pui, C. H. (2005). Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. American Journal of Neuroradiology, 26, 1263-1269.
41. Reddick, W. E., Shan, Z. Y., Glass, J. O., Helton, S., Xiong, X., Wu, S., & Mulhern, R. K. (2006). Smaller white-matter volumes are associated with larger deficits in attention and learning among longterm survivors of acute lymphoblastic leukemia. Cancer, 106, 941-949.
42. Reddick, W. E., White, H. A., Glass, J O., Wheeler, G. C., Thompson, S. J., Gajjar, A., & Mulhern, R. K. (2003). Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer, 97, 2512-2519.
43. Roberts, L., & Morrow, J. (2000). Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology & Medicine, 28, 505-513.
44. Rouse, K., Nwokedi, E., Woodliffe, J. E., Epstein, J., & Klimberg, V. S. (1995). Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Annals of Surgery, 221, 420-426.
45. Stenzel, S. L., Krull, K. R., Hockenberry, M., Jain, N., Kaemingk, K., Miketova, P., & Moore, I. M. (2010). Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy. Journal of Pediatric Hematology/ Oncology, 32, 113-118.
46. Verstraeten, S. V., Golul, M. S., Keen, C. L., & Oteiza, P. I. (1997). Myelin is a preferential target of aluminum-mediated oxidative damage. Archives of Biochemistry and Biophysics, 344, 289-294.
47. Waber, D. B., & Tarbell, N. J. (1997). Toxicity of CNS prophylaxis for childhood leukemia. Oncology (Williston Park), 11, 259-264.
48. Waber, D. P., Tarbell, N. J., Fairclough, D., Atmore, K., Castro, R., Isquith, P., & Schiller, M. (1995). Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: Cranial radiation requires an accomplice. Journal of Clinical Oncology, 13, 2490-2496.